Reuters: Regulatory News: Pfizer, Bristol-Myers get EU approval for blood clot preventer

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

Pfizer, Bristol-Myers get EU approval for blood clot preventer Nov 20th 2012, 19:13 Tue Nov 20, 2012 2:13pm EST Nov 20 (Reuters) - European health regulators on Tuesday approved an eagerly anticipated blood thinner developed by Bristol-Myers Squibb Co and Pfizer Inc for the prevention of strokes and blood clots in patients who have an irregular heartbeat known as atrial fibrillation, the companies said. The drug Eliquis, also known as apixaban, is widely considered one of the most important new products for the two U.S. drugmakers, with multibillion-dollar annual sales potential. The U.S. Food and Drug Administration is expected to make its decision on the drug for use in the world's biggest market by March 17, after delaying a decision in June so that the agency could review additional information from clinical trials of the medicine.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions